In Practise Logo
In Practise Logo - Blue
In Practise Logo
IP Interview
Published July 7, 2023

TransDigm: Esterline Acquisition & ScioTeq Spin

Executive Bio

Former President at Esterline Technologies & CEO of ScioTeq

Interview Transcript

Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.

This is a snippet of the transcript.to get full access.

What were the margins for those businesses? How profitable were they?

When Barco's business was sold to Esterline, it was marginally profitable. It was so-so from Esterline to TransDigm. Under Esterline, we began to reorganize, and part of the journey to higher profitability was completed. This was due to the mindset that we needed two production sites for the same products, one in the US and one in Belgium, to support the US market better. Eventually, we saw that that didn't work any more and decided to close the factory in the US, which generated additional profits. The second part of the return to profitability journey was under TransDigm, which decided to close an additional site in Toulouse.

This is a snippet of the transcript.to get full access.

Free Sample of 50+ Interviews

Sign up to test our content quality with a free sample of 50+ interviews.

Or contact sales for full access

© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.